Wild reason man kidnapped brother-in-law
UnitedHealth Group stock opened at $295.37 on Tuesday. The company has a market cap of $267.94 billion, a P/E ratio of 19.06, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The company has a fifty day simple moving average of $448.25 and a 200 day simple moving average of $501.48. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period last year, the business posted $6.91 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year. Insiders Place Their Bets
In other UnitedHealth Group news, CEO Stephen J. Hemsley bought 86,700 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The shares were purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at $196,081,295.01. The trade was a 14.63% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kristen Gil acquired 3,700 shares of UnitedHealth Group stock in a transaction dated Thursday, May 15th. The stock was purchased at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock valued at $31,607,768 in the last ninety days. 0.33% of the stock is currently owned by insiders. Hedge Funds Weigh In On UnitedHealth Group
Several hedge funds and other institutional investors have recently made changes to their positions in the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $28,000. Bayforest Capital Ltd grew its stake in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 48 shares during the last quarter. Finally, AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $30,000. 87.86% of the stock is currently owned by institutional investors and hedge funds. Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on UNH. Bank of America downgraded shares of UnitedHealth Group from a 'buy' rating to a 'neutral' rating and decreased their price objective for the company from $560.00 to $350.00 in a research report on Wednesday, May 14th. Barclays decreased their price objective on shares of UnitedHealth Group from $513.00 to $362.00 and set an 'overweight' rating for the company in a research report on Thursday, May 15th. Erste Group Bank cut shares of UnitedHealth Group from a 'strong-buy' rating to a 'hold' rating in a research note on Wednesday, April 30th. HSBC restated a 'reduce' rating and set a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Finally, Raymond James cut shares of UnitedHealth Group from a 'strong-buy' rating to a 'market perform' rating in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of 'Moderate Buy' and an average price target of $441.87.
Check Out Our Latest Research Report on UNH About Representative McGuire
John McGuire (Republican Party) is a member of the U.S. House, representing Virginia's 5th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
McGuire (Republican Party) is running for re-election to the U.S. House to represent Virginia's 5th Congressional District. He declared candidacy for the 2026 election.
John McGuire was born in Richmond, Virginia. McGuire graduated from Henrico High School. He served as a U.S. Navy Seal from 1988 to 1998. His professional experience includes founding SEAL Team Physical Training Inc. About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. Featured Articles
companies with MarketBeat.com's FREE daily email newsletter.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sydney Morning Herald
a day ago
- Sydney Morning Herald
ASX set to fall, Wall Street mixed; Microsoft, Meta surge
Stocks indexes were mixed in afternoon trading on Wall Street after a health care sector slide offset some of the gains from a rally among big tech companies. The S&P 500 was up less than 0.1 per cent, holding just below the record high it set on Monday. The Dow Jones Industrial Average fell 88 points, or 0.2 per cent. The technology-heavy Nasdaq rose 0.3 per cent and is on track for a record. The Australian sharemarket is set to retreat, with futures at 5.10am AEST pointing to a loss of 52 points, or 0.6 per cent, at the open. The ASX lost 0.2 per cent on Thursday. The Australian dollar was fetching 64.33 US cents at 5.25am. Health care stocks were the biggest drag on the market after the White House released letters asking big pharmaceutical companies to cut prices and make other changes in the next 60 days. Eli Lilly & Co. fell 2 per cent, UnitedHealth Group slid 4.9 per cent and Bristol-Myers Squibb was 4.5 per cent lower. Roughly 70 per cent of stocks in the S&P 500 were losing ground, but big technology stocks with hefty values helped temper the impact of losses in health care and other sectors. Loading Technology stocks rose following results from big companies showcasing advancements in artificial intelligence. Facebook and Instagram's parent company Meta Platforms surged 11.9 per cent after it crushed Wall Street's sales and profit targets even as the company continues to pour billions into artificial intelligence. Microsoft jumped 4.1 per cent after also posting better results than analysts expected. The software pioneer also gave investors an encouraging update on its Azure cloud computing platform, which is a centrepiece of the company's artificial intelligence efforts.
The Age
a day ago
- The Age
ASX set to fall, Wall Street mixed; Microsoft, Meta surge
Stocks indexes were mixed in afternoon trading on Wall Street after a health care sector slide offset some of the gains from a rally among big tech companies. The S&P 500 was up less than 0.1 per cent, holding just below the record high it set on Monday. The Dow Jones Industrial Average fell 88 points, or 0.2 per cent. The technology-heavy Nasdaq rose 0.3 per cent and is on track for a record. The Australian sharemarket is set to retreat, with futures at 5.10am AEST pointing to a loss of 52 points, or 0.6 per cent, at the open. The ASX lost 0.2 per cent on Thursday. The Australian dollar was fetching 64.33 US cents at 5.25am. Health care stocks were the biggest drag on the market after the White House released letters asking big pharmaceutical companies to cut prices and make other changes in the next 60 days. Eli Lilly & Co. fell 2 per cent, UnitedHealth Group slid 4.9 per cent and Bristol-Myers Squibb was 4.5 per cent lower. Roughly 70 per cent of stocks in the S&P 500 were losing ground, but big technology stocks with hefty values helped temper the impact of losses in health care and other sectors. Loading Technology stocks rose following results from big companies showcasing advancements in artificial intelligence. Facebook and Instagram's parent company Meta Platforms surged 11.9 per cent after it crushed Wall Street's sales and profit targets even as the company continues to pour billions into artificial intelligence. Microsoft jumped 4.1 per cent after also posting better results than analysts expected. The software pioneer also gave investors an encouraging update on its Azure cloud computing platform, which is a centrepiece of the company's artificial intelligence efforts.
AU Financial Review
23-07-2025
- AU Financial Review
The $40m bet that saved Australian rugby
In May 2021, a US investment firm took a leap of faith on a struggling Australian sport. Ares Management, a NYSE-listed asset manager, was starting to put its stamp on the global sports industry and Rugby Australia, the local governing body of rugby union, was running out of cash.
